Pneumonectomy after neoadjuvant immunotherapy combined with chemotherapy is a safe and effective option for central non-small-cell lung cancer patients, a single-center experience
In our research, we proved that pneumonectomy following neoadjuvant immunotherapy combined with chemotherapy, was safe, and effective, which also brought survival benefits to locally advanced central NSCLC patients.
Authors
- Di Ge (ORCID: https://orcid.org/0000-0001-5241-1766)
- Tao Cheng (ORCID: https://orcid.org/0000-0002-5925-2769)
- Xiaolong Huang (ORCID: https://orcid.org/0000-0001-8187-2289)
- Chunlai Lu
- Huiqin Yang (ORCID: https://orcid.org/0000-0003-3985-986X)
- Teng Ma (ORCID: https://orcid.org/0000-0002-5849-2138)
- Fengkai Xu
- Jie Gu (ORCID: https://orcid.org/0009-0009-0709-5237)
Institutions
- Sun Yat-sen University (CN)
- Fudan University (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Journal of Thoracic Disease
- Published
- 2025-05-01
- DOI
- https://doi.org/10.21037/jtd-24-1923
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 1.52